CS logo
small CS logo
Orlando Health Cancer Institute

Orlando, Florida, United States
Cancer treatment center in Lake Mary, Florida
210 Rinehart Rd, Lake Mary, FL 32746

About Orlando Health Cancer Institute


"Orlando Health UF Health Cancer Center - Lake Mary provides expert cancer care in a convenient, community-based location. Patients in the Lake Mary and Seminole County communities can access advanced, personalized cancer treatment from a diverse team of specialists that are part of the only Cancer Center of Excellence in Central Florida. Our services include medical oncology and radiation oncology appointments, as well as chemotherapy treatments and laboratory and diagnostic services. Orlando Health UF Health Cancer Center - Lake Mary also provides cancer support services, including nutritionists, support groups and counselors."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
73
Children's Oncology Group
36
NRG Oncology
11
Bristol-Myers Squibb
10
Pfizer
9
Alliance for Clinical Trials in Oncology
8
SWOG Cancer Research Network
7
Gynecologic Oncology Group
6
Hoffmann-La Roche
5
NSABP Foundation Inc
5
GOG Foundation
4
Total Rows: 62

Clinical Trials at Orlando Health Cancer Institute


During the past decade, Orlando Health Cancer Institute conducted 97 clinical trials. In the 10-year time frame, 97 clinical trials started and 106 clinical trials were completed, i.e. on average, 109.3% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 50 clinical trials were completed. i.e. 200% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years15151111191910101717881111664411112222991010222212121111Started TrialsCompleted Trails201520162017201820192020202120220102030
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma
2001-10-18
Active, not recruiting
1,449
Dose-Escalating and Safety Study of CP-461 in Patients With Chronic Lymphocytic Leukemia
2002-03-01
2003-04-01
Completed
15
An Open Label Study of a Peptide Vaccine in Patients With Stage IIb or IIIa Non-Small Cell Lung Cancer
2003-01-01
Completed
18
An Open Label Study of a Peptide Vaccine in Patients With Stage III Colon Cancer
2003-02-01
Completed
18
Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer
2003-08-25
2021-01-05
Completed
1,381
Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Cancer of the Vulva
2005-01-01
2012-01-20
Completed
61
Imatinib Mesylate or Dasatinib in Treating Patients With Previously Untreated Chronic Phase Chronic Myelogenous Leukemia
2004-08-15
Active, not recruiting
406
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
2003-12-29
2021-03-31
Completed
3,154

Rows per page:

1–100 of 247

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Orlando Health Cancer Institute" #1 sponsor was "National Cancer Institute (NCI)" with 73 trials, followed by "Children's Oncology Group" with 36 trials sponsored, "NRG Oncology" with 11 trials sponsored, "Bristol-Myers Squibb" with 10 trials sponsored and "Pfizer" with 10 trials sponsored. Other sponsors include 103 different institutions and companies that sponsored additional 62 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Orlando Health Cancer Institute" #1 collaborator was "National Cancer Institute (NCI)" with 82 trials as a collaborator, "NRG Oncology" with 23 trials as a collaborator, "Radiation Therapy Oncology Group" with 7 trials as a collaborator, "Genentech, Inc." with 5 trials as a collaborator and "Merck Sharp & Dohme LLC" with 4 trials as a collaborator. Other collaborators include 57 different institutions and companies that were collaborators in the rest 51 trials.
Created with Highcharts 11.1.0Top Leading SponsorsNational CancerInstitute (NCI): 73National CancerInstitute (NCI): 73Children's Oncology Group: 36Children's Oncology Group: 36NRG Oncology: 11NRG Oncology: 11Bristol-Myers Squibb: 10Bristol-Myers Squibb: 10Pfizer: 9Pfizer: 9Alliance for ClinicalTrials in Oncology: 8Alliance for ClinicalTrials in Oncology: 8SWOG Cancer ResearchNetwork: 7SWOG Cancer ResearchNetwork: 7Gynecologic Oncology Group: 6Gynecologic Oncology Group: 6Hoffmann-La Roche: 5Hoffmann-La Roche: 5NSABP Foundation Inc: 5NSABP Foundation Inc: 5

Created with Highcharts 11.1.0Top CollaboratorsNational CancerInstitute (NCI): 82National CancerInstitute (NCI): 82NRG Oncology: 23NRG Oncology: 23Radiation TherapyOncology Group: 7Radiation TherapyOncology Group: 7Genentech, Inc.: 5Genentech, Inc.: 5Merck Sharp & Dohme LLC: 4Merck Sharp & Dohme LLC: 4NCIC Clinical Trials Group: 4NCIC Clinical Trials Group: 4SWOG Cancer ResearchNetwork: 4SWOG Cancer ResearchNetwork: 4Canadian Cancer Trials Group: 3Canadian Cancer Trials Group: 3AbbVie: 2AbbVie: 2Cancer and LeukemiaGroup B: 2Cancer and LeukemiaGroup B: 2

Clinical Trials Conditions at Orlando Health Cancer Institute


According to Clinical.Site data, the most researched conditions in "Orlando Health Cancer Institute" are "Breast Cancer" (14 trials), "Melanoma" (9 trials), "Acute Lymphoblastic Leukemia" (8 trials), "Fallopian Tube Transitional Cell Carcinoma" (8 trials) and "Fallopian Tube Endometrioid Adenocarcinoma" (7 trials). Many other conditions were trialed in "Orlando Health Cancer Institute" in a lesser frequency.

Clinical Trials Intervention Types at Orlando Health Cancer Institute


Most popular intervention types in "Orlando Health Cancer Institute" are "Drug" (189 trials), "Other" (117 trials), "Biological" (80 trials), "Radiation" (60 trials) and "Procedure" (39 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (69 trials), "Quality-of-Life Assessment" (47 trials), "Cisplatin" (29 trials), "Carboplatin" (27 trials) and "Cyclophosphamide" (25 trials). Other intervention names were less common.

Clinical Trials Genders at Orlando Health Cancer Institute


The vast majority of trials in "Orlando Health Cancer Institute" are 196 trials for "All" genders, 44 trials for "Female" genders and 6 trials for "Male" genders.

Clinical Trials Status at Orlando Health Cancer Institute


Currently, there are NaN active trials in "Orlando Health Cancer Institute". undefined are not yet recruiting, 42 are recruiting, 98 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 76 completed trials in Orlando Health Cancer Institute, 5 suspended trials, and 16 terminated clinical trials to date.
Out of the total trials that were conducted in Orlando Health Cancer Institute, 18 "Phase 1" clinical trials were conducted, 85 "Phase 2" clinical trials and 133 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 133Phase 3: 133Phase 2: 85Phase 2: 85Phase 1: 18Phase 1: 18Not Applicable: 3Not Applicable: 3Early Phase 1: 1Early Phase 1: 1Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 98Active, not recruiting: 98Completed: 76Completed: 76Recruiting: 42Recruiting: 42Terminated: 16Terminated: 16Suspended: 5Suspended: 5Unknown status: 5Unknown status: 5Available: 2Available: 2No longer available: 2No longer available: 2Withdrawn: 1Withdrawn: 1